201 related articles for article (PubMed ID: 22512596)
1. Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration.
Pawar VK; Kansal S; Asthana S; Chourasia MK
Expert Opin Drug Deliv; 2012 May; 9(5):551-65. PubMed ID: 22512596
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
Pahwa R; Saini N; Kumar V; Kohli K
Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
[TBL] [Abstract][Full Text] [Related]
3. Excipients with specialized functions for effective drug delivery.
Hamman J; Steenekamp J
Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
[TBL] [Abstract][Full Text] [Related]
4. QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.
Singh B; Kaur A; Dhiman S; Garg B; Khurana RK; Beg S
AAPS PharmSciTech; 2016 Apr; 17(2):454-65. PubMed ID: 26238805
[TBL] [Abstract][Full Text] [Related]
5. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
Agrawal AK; Das M; Jain S
Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
[TBL] [Abstract][Full Text] [Related]
6. Novel prospective in colon specific drug delivery system.
Bansal V; Malviya R; Malaviya T; Sharma PK
Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
[TBL] [Abstract][Full Text] [Related]
7. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.
Kotta S; Khan AW; Pramod K; Ansari SH; Sharma RK; Ali J
Expert Opin Drug Deliv; 2012 May; 9(5):585-98. PubMed ID: 22512597
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
Wang R; Conner DP; Li BV
AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical applications of cyclodextrins: basic science and product development.
Loftsson T; Brewster ME
J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
[TBL] [Abstract][Full Text] [Related]
10. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?
Awasthi R; Kulkarni GT
Drug Deliv; 2016; 23(2):378-94. PubMed ID: 25026414
[TBL] [Abstract][Full Text] [Related]
11. Modeling and simulation of biopharmaceutical performance.
Zhang X; Lionberger RA
Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
[TBL] [Abstract][Full Text] [Related]
12. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.
Pawar VK; Kansal S; Garg G; Awasthi R; Singodia D; Kulkarni GT
Drug Deliv; 2011 Feb; 18(2):97-110. PubMed ID: 20958237
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
14. Gastroretentive floating drug-delivery systems: a critical review.
Kotreka UK; Adeyeye MC
Crit Rev Ther Drug Carrier Syst; 2011; 28(1):47-99. PubMed ID: 21395515
[TBL] [Abstract][Full Text] [Related]
15. Formulation strategies for absorption windows.
Davis SS
Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
[TBL] [Abstract][Full Text] [Related]
16. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
[TBL] [Abstract][Full Text] [Related]
17. Drug release from liquisolid systems: speed it up, slow it down.
Nokhodchi A; Hentzschel CM; Leopold CS
Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
[TBL] [Abstract][Full Text] [Related]
18. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
Bandari S; Eaga CM; Thadishetty A; Yamsani MR
Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
[TBL] [Abstract][Full Text] [Related]
20. Model predicting impact of complexation with cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2013 Sep; 110(9):2536-47. PubMed ID: 23592239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
